Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (5)

1

Etravirine limits the emergence of darunavir and other protease inhibitor resistance-associated mutations in the DUET trials

enthalten in: AIDS (London, England) | 2010

von Peeters, M. | Vingerhoets, J. | Tambuyzer, L. | +4

2

Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients

enthalten in: AIDS (London, England) | 2009

von De Meyer, S. | Lathouwers, E. | Dierynck, I. | +7

3

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48

enthalten in: AIDS (London, England) | 2008

von Ortiz, R. | Dejesus, E. | Khanlou, H. | +9

4

Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients"

enthalten in: AIDS (London, England) | 2008

von Picchio, G. | De Meyer, S. | de Béthune, M.

CommentOn: AIDS. 2007 May 31;21(9):1210-3. - PMID 17502734

5

TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen : a 14-day proof-of-principle trial

enthalten in: AIDS (London, England) | 2005

von Arastéh, K. | Clumeck, N. | Pozniak, A. | +7

1
[1]